XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Note 13 - Equity-based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]

(in thousands, except years
and per share data)

 

Awards

  

Weighted-

Average

Exercise

Price

  

Weighted-

Average

Remaining

Contractual

Life (years)

  

Aggregate

Intrinsic

Value

 

Outstanding at December 31, 2022

  132  $37.99   7.5  $69 
                 

Options granted

  42  $1.67         

Restricted stock units granted

  5            

Restricted stock units vested

  (5

)

           

Options forfeited/cancelled

  (19

)

 $64.23         

Restricted stock units cancelled

  (7

)

           

Outstanding at September 30, 2023

  148  $26.26   7.6  $13 
                 

Vested and expected to vest at September 30, 2023

  119  $32.34   7.5  $2 
                 

Vested at September 30, 2023

  59  $59.30   5.8  $ 
                 

Exercisable at September 30, 2023

  59  $59.30   5.8  $ 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
  

2023

  

2022

  

2023

  

2022

 

Research and development

 $5  $5  $16  $14 

Sales and marketing

  18   12   49   37 

General and administrative

  39   (225

)

  136   79 

Total stock-based compensation expense

 $62  $(208

)

 $201  $130 
Employees and Directors [Member]  
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Nine Months Ended September 30,

 

Assumption

 

2023

  

2022

 

Expected price volatility

  152.99

%

  158.04

%

Expected term (in years)

  6.81   6.45 

Risk-free interest rate

  3.47

%

  2.29

%

Dividend yield

  0.00

%

  0.00

%

Weighted-average fair value of options granted during the period

 $1.61  $9.46